Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus patients with moderate to severe renal impairment: a systematic review and meta-analysis

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
chronic kidney disease 1 nephrologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
chronic kidney disease 2728 its Supporting Information files.IntroductionThe prevalence of type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) is increasing steadily. Diabetes is the leading cause of CKD, which might progress to end-stage

You must be authorized to submit a review.